Y-mAbs to resubmit U.S. marketing application for neuroblastoma therapy in Q1 2022
February 11 2022 - 9:22AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Y mAbs Therapeutics (NASDAQ:YMAB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Y mAbs Therapeutics (NASDAQ:YMAB)
Historical Stock Chart
From Apr 2023 to Apr 2024